These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 2867156)

  • 21. [Study on dissolution test in vitro and bioavailability of oral osmotic pump of verapamil hydrochloride].
    Guo JL; Jing GW; Cao DS; Li YQ; He HY; Ling LX; Li Z
    Yao Xue Xue Bao; 1993; 28(9):714-20. PubMed ID: 8010021
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Spline functions in convolutional modeling of verapamil bioavailability and bioequivalence. II: study in healthy volunteers.
    Popović J; Mitić R; Sabo A; Mikov M; Jakovljević V; Daković-Svajcer K
    Eur J Drug Metab Pharmacokinet; 2006; 31(2):87-96. PubMed ID: 16898076
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Influence of food on the bioavailability of a sustained-release verapamil preparation.
    Conway EL; Phillips PA; Drummer OH; Louis WJ
    J Pharm Sci; 1990 Mar; 79(3):228-31. PubMed ID: 2338632
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacokinetics of conventional and slow-release verapamil.
    Follath F; Ha HR; Schütz E; Bühler F
    Br J Clin Pharmacol; 1986; 21 Suppl 2(Suppl 2):149S-153S. PubMed ID: 3756058
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Design and evaluation of floating multi-layer coated tablets based on gas formation.
    Sungthongjeen S; Sriamornsak P; Puttipipatkhachorn S
    Eur J Pharm Biopharm; 2008 May; 69(1):255-63. PubMed ID: 17967527
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Enteric coated quinidine compared to sustained release preparations during repeated administration.
    Bakke OM; Aanderud L; Aslaksen A
    Acta Med Scand; 1980; 207(3):183-7. PubMed ID: 7368984
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sustained Release Bilayer Tablet of Ibuprofen and Phenylephrine Hydrochloride: Preparation and Pharmacokinetics in Beagle Dogs.
    Zhu C; Xu S; Han X; Wang W; He W; Yin L; Yang L; Qin C
    AAPS PharmSciTech; 2019 Jan; 20(2):86. PubMed ID: 30673916
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Verapamil disposition and effect on PQ-intervals after buccal, oral and intravenous administration.
    Asthana OP; Woodcock BG; Wenchel M; Frömming KH; Schwabe L; Rietbrock N
    Arzneimittelforschung; 1984; 34(4):498-502. PubMed ID: 6540109
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Design and evaluation of 1- and 3-layer matrices of verapamil hydrochloride for sustaining its release.
    Siahi MR; Barzegar-Jalali M; Monajjemzadeh F; Ghaffari F; Azarmi S
    AAPS PharmSciTech; 2005 Dec; 6(4):E626-32. PubMed ID: 16408864
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Simultaneous determination of the intravenous and oral pharmacokinetic parameters of D,L-verapamil using stable isotope-labelled verapamil.
    Eichelbaum M; Somogyi A; von Unruh GE; Dengler HJ
    Eur J Clin Pharmacol; 1981 Jan; 19(2):133-7. PubMed ID: 7202473
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Preparation and in vitro/in vivo evaluation of sustained-release metformin hydrochloride pellets.
    Hu LD; Liu Y; Tang X; Zhang Q
    Eur J Pharm Biopharm; 2006 Oct; 64(2):185-92. PubMed ID: 16797948
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Faster clearance of sustained release verapamil in men versus women: continuing observations on sex-specific differences after oral administration of verapamil.
    Krecic-Shepard ME; Barnas CR; Slimko J; Schwartz JB
    Clin Pharmacol Ther; 2000 Sep; 68(3):286-92. PubMed ID: 11014410
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacokinetics of ibuprofen following a single administration of a suspension containing enteric-coated microcapsules.
    Walter K; Weiss G; Laicher A; Stanislaus F
    Arzneimittelforschung; 1995 Aug; 45(8):886-90. PubMed ID: 7575754
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A novel approach to sustained pseudoephedrine release: differentially coated mini-tablets in HPMC capsules.
    Ishida M; Abe K; Hashizume M; Kawamura M
    Int J Pharm; 2008 Jul; 359(1-2):46-52. PubMed ID: 18467046
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Circadian variation in the pharmacokinetics of verapamil.
    Jespersen CM; Frederiksen M; Hansen JF; Klitgaard NA; Sørum C
    Eur J Clin Pharmacol; 1989; 37(6):613-5. PubMed ID: 2612558
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differences in oral verapamil absorption as a function of time of day.
    Eldon MA; Battle MM; Voigtman RE; Colburn WA
    J Clin Pharmacol; 1989 Nov; 29(11):989-93. PubMed ID: 2600194
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Development of novel fast-dissolving tacrolimus solid dispersion-loaded prolonged release tablet.
    Cho JH; Kim YI; Kim DW; Yousaf AM; Kim JO; Woo JS; Yong CS; Choi HG
    Eur J Pharm Sci; 2014 Apr; 54():1-7. PubMed ID: 24388864
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Use of an in vitro absorption model system for predicting sustained release of verapamil.
    Neubert R; Fahr F; Mäder C; Lücke L; Fries G; Rostock G
    Arzneimittelforschung; 1992 Sep; 42(9):1098-100. PubMed ID: 1445475
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacokinetic profile and bioavailability of a new galenic formulation of ticlopidine.
    Desager JP; van Nieuwenhuyze Y; Dricot J; Berger Y; Harvengt C
    Int J Clin Pharmacol Res; 1990; 10(4):247-50. PubMed ID: 2079383
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A single-dose, three-period, six-sequence crossover study comparing the bioavailability of solution, suspension, and enteric-coated tablets of magnesium valproate in healthy Mexican volunteers under fasting conditions.
    Marcelín-Jiménez G; Angeles-Moreno AP; Contreras-Zavala L; Morales-Martínez M; Rivera-Espinosa L
    Clin Ther; 2009 Sep; 31(9):2002-11. PubMed ID: 19843490
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.